Drug Trial Radar · NCT03894215
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer
Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
211
Actual
Start
Jun 1, 2019
Primary completion
Mar 26, 2025
Study completion Mar 26, 2025
Sponsor
- Lead sponsor
- Agenus Inc.Industry
- Sponsor type
- Industry
- Collaborators
- GOG Foundation
- First posted
- Mar 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placebo (Treatment Arm 1 - monotherapy) or with AGEN1884 (Treatment Arm 2- combination therapy) for treatment of patients with advanced cervical cancer who relapsed or progressed after receiving first-line platinum-based chemotherapy. The study is not intended to compare the efficacy of the 2 experimental arms. Rather, the efficacy of each arm will be evaluated against its relevant historical controls as appropriate.
Conditions
- Cervical Cancer
Interventions
AGEN2034Drug
PD-1 antibody
AGEN1884Drug
CTLA-4 antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response RateTime frame: 48 months
Locations
68 sites in 7 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham School of Medicine
Birmingham, Alabama
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama
Arizona Oncology - Biltmore Cancer Center
Phoenix, Arizona
Arizona Oncology - Tucson - Wilmot Road Location
Tucson, Arizona
University of California, San Diego (UCSD) - Moores Cancer Center
La Jolla, California
UCLA- Women's Health Clinical Research Unit (WHCRU)
Los Angeles, California
Gynecologic Oncology Associates
Newport, California
California Pacific Medical Center
San Francisco, California
University of California, San Francisco Medical Center
San Francisco, California
Baptist MD Anderson Cancer Center
Jacksonville, Florida
Moffitt Cancer Center
Tampa, Florida
Northside Hospital
Atlanta, Georgia
St Joseph's Hospital
Savannah, Georgia
Community Health Network - North Cancer Center
Indianapolis, Indiana
University of Kentucky Albert B. Chandler Hospital
Lexington, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
MD Anderson Cancer Center at Cooper
Camden, New Jersey
University of New Mexico Cancer Center
Albuquerque, New Mexico
Northwell Health Monter Cancer Center
Lake Success, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York
SUNY Upstate Medical University
Syracuse, New York
Albert Einstein College of Medicine
The Bronx, New York
Levine Cancer Institute
Charlotte, North Carolina
FirstHealth Outpatient Cancer Center
Pinehurst, North Carolina
MetroHealth Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Columbus NCORP
Columbus, Ohio
Stephenson Cancer Center
Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute, LLC
Tulsa, Oklahoma
Willamette Valley Cancer Institute
Eugene, Oregon
Northwest Cancer Specialists, P.C.
Portland, Oregon
Penn Medicine - Jordan Center for Gynecologic Cancer
Philadelphia, Pennsylvania
WellSpan Gynecologic Oncology
York, Pennsylvania
Women & Infants Hospital of Rhode Island
Providence, Rhode Island
Texas Oncology Surgical Specialists - Austin Central
Austin, Texas
Texas Oncology - Bedford
Bedford, Texas
Texas Oncology - Dallas - Presbyterian Cancer Center
Dallas, Texas
The University of Texas Southwestern Medical Center
Dallas, Texas
Texas Oncology - Fort Worth Cancer Center
Fort Worth, Texas
Texas Oncology - San Antonio Medical Center
San Antonio, Texas
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.